Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Andre

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|April 5, 2001
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factorsW Jacot, X Quantin, J M Boher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2014
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter studyM V Dieci, C Criscitiello, A Goubar, et al.
European Heart Journal|August 1, 1997
Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study GroupN Meneveau, J P Bassand, C Bauters, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancerE Massarelli, F Andre, D D Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implicationsF Andre, D Grunenwald, J P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter studyM V Dieci, C Criscitiello, A Goubar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2019
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approachC Luchini, F Bibeau, M J L Ligtenberg, et al.
European Journal of Biochemistry|February 7, 1998
Metabolism of tentoxin by hepatic cytochrome P-450 3A isozymesM Delaforge, F Andre, M Jaouen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2007
Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trialsR Conforti, T Boulet, G Tomasic, et al.
Journal of Chromatography. A|October 20, 2005
Application of stable carbon isotope analysis to the detection of 17beta-estradiol administration to cattleC Buisson, M Hebestreit, A Preiss Weigert, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|April 5, 2001
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factorsW Jacot, X Quantin, J M Boher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2014
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter studyM V Dieci, C Criscitiello, A Goubar, et al.
European Heart Journal|August 1, 1997
Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study GroupN Meneveau, J P Bassand, C Bauters, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancerE Massarelli, F Andre, D D Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implicationsF Andre, D Grunenwald, J P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter studyM V Dieci, C Criscitiello, A Goubar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2019
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approachC Luchini, F Bibeau, M J L Ligtenberg, et al.
European Journal of Biochemistry|February 7, 1998
Metabolism of tentoxin by hepatic cytochrome P-450 3A isozymesM Delaforge, F Andre, M Jaouen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2007
Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trialsR Conforti, T Boulet, G Tomasic, et al.
Journal of Chromatography. A|October 20, 2005
Application of stable carbon isotope analysis to the detection of 17beta-estradiol administration to cattleC Buisson, M Hebestreit, A Preiss Weigert, et al.
Pageof 12